| human | Q5 |
| P496 | ORCID iD | 0000-0002-8701-9462 |
| P734 | family name | Pichler | Q16796481 |
| Pichler | Q16796481 | ||
| Pichler | Q16796481 | ||
| P735 | given name | Martin | Q18002399 |
| Martin | Q18002399 | ||
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | male | Q6581097 |
| Q40853317 | Association of the Derived Neutrophil-Lymphocyte Ratio With Critical Limb Ischemia |
| Q98618544 | C-Reactive Protein (CRP) Levels in Immune Checkpoint Inhibitor Response and Progression in Advanced Non-Small Cell Lung Cancer: A Bi-Center Study |
| Q57180572 | Continuous, label-free, 96-well-based determination of cell migration using confluence measurement |
| Q37878541 | Current status of therapeutic targeting of developmental signalling pathways in oncology. |
| Q94582754 | Decreased Activity of Circulating Butyrylcholinesterase in Blood Is an Independent Prognostic Marker in Pancreatic Cancer Patients |
| Q28073195 | Deregulated MicroRNAs in Biliary Tract Cancer: Functional Targets and Potential Biomarkers |
| Q64963546 | Early Loss of Forkhead Transcription Factor, O Subgroup, Member 1 Protein in the Development of Pancreatic Ductal Adenocarcinoma. |
| Q30844815 | Exosomal miR-940 maintains SRC-mediated oncogenic activity in cancer cells: a possible role for exosomal disposal of tumor suppressor miRNAs |
| Q96348567 | External validation of the prognostic relevance of the advanced lung cancer inflammation index (ALI) in pancreatic cancer patients |
| Q112302934 | Fasting improves therapeutic response in hepatocellular carcinoma through p53-dependent metabolic synergism |
| Q91602127 | Generation of An Endogenous FGFR2-BICC1 Gene Fusion/58 Megabase Inversion Using Single-Plasmid CRISPR/Cas9 Editing in Biliary Cells |
| Q39416069 | Genome-Wide miRNA Analysis Identifies miR-188-3p as a Novel Prognostic Marker and Molecular Factor Involved in Colorectal Carcinogenesis. |
| Q30836400 | H19 Noncoding RNA, an Independent Prognostic Factor, Regulates Essential Rb-E2F and CDK8-β-Catenin Signaling in Colorectal Cancer |
| Q98162636 | Hazard Curves for Tumor Recurrence and Tumor-Related Death Following Esophagectomy for Esophageal Cancer |
| Q44720968 | Histiocytic sarcoma - targeted therapy: novel therapeutic options? A series of 4 cases |
| Q89891797 | Immunohistochemistry for c-myc and bcl-2 overexpression improves risk stratification in primary central nervous system lymphoma |
| Q50958158 | Inflammatory Biomarkers in Diffuse Large B-Cell Lymphoma: Time for Extending the Established Prognosis Scores? |
| Q100383220 | Involvement of Long Non-Coding RNAs (lncRNAs) in Tumor Angiogenesis |
| Q91205837 | Involvement of long non-coding RNA HULC (highly up-regulated in liver cancer) in pathogenesis and implications for therapeutic intervention |
| Q60921039 | Involvement of the long noncoding RNA NEAT1 in carcinogenesis |
| Q94593133 | Long Non-Coding RNA PANTR1 is Associated with Poor Prognosis and Influences Angiogenesis and Apoptosis in Clear-Cell Renal Cell Cancer |
| Q93211281 | Long Non-Coding RNAs in Biliary Tract Cancer-An Up-to-Date Review |
| Q58542505 | Long non-coding RNA CCAT2 as a therapeutic target in colorectal cancer |
| Q97522602 | Long-Noncoding RNA (lncRNA) in the Regulation of Hypoxia-Inducible Factor (HIF) in Cancer |
| Q35793756 | Low spinophilin expression enhances aggressive biological behavior of breast cancer. |
| Q59137532 | Metformin blocks MYC protein synthesis in colorectal cancer via mTOR-4EBP-eIF4E and MNK1-eIF4G-eIF4E signaling |
| Q37706967 | MicroRNA 603 acts as a tumor suppressor and inhibits triple-negative breast cancer tumorigenesis by targeting elongation factor 2 kinase |
| Q33721764 | N-BLR, a primate-specific non-coding transcript leads to colorectal cancer invasion and migration |
| Q104061353 | Non-Coding RNAs and SARS-Related Coronaviruses |
| Q90812780 | Non-Coding microRNAs as Novel Potential Tumor Markers in Testicular Cancer |
| Q38826546 | Non-coding RNAs Enabling Prognostic Stratification and Prediction of Therapeutic Response in Colorectal Cancer Patients |
| Q93262609 | RNA-Binding Proteins as Important Regulators of Long Non-Coding RNAs in Cancer |
| Q100689824 | Stage-Specific Value of Carbohydrate Antigen 19-9 and Carcinoembryonic Antigen Serum Levels on Survival and Recurrence in Pancreatic Cancer: A Single Center Study and Meta-Analysis |
| Q51233278 | Successful use of sorafenib after bortezomib failure in metastatic follicular thyroid cancer - a case report. |
| Q97413777 | The Lipase/Amylase Ratio (LAR) in Peripheral Blood Might Represent a Novel Prognostic Marker in Patients with Surgically Resectable Pancreatic Cancer |
| Q96820124 | The Role of Immunohistochemical Overexpression of p53 as Adverse Prognostic Factor in Primary Testicular Diffuse Large B Cell Lymphoma |
| Q36090214 | The clinical and biological significance of MIR-224 expression in colorectal cancer metastasis |
| Q38271374 | The role of polycomb repressive complexes in biliary tract cancer. |
| Q92977371 | Therapeutic potential of FLANC, a novel primate-specific long non-coding RNA in colorectal cancer |
| Q114252555 | Trends and Patterns in the Public Awareness of Palliative Care, Euthanasia, and End-of-Life Decisions in 3 Central European Countries Using Big Data Analysis From Google: Retrospective Analysis |
| Q52844139 | Ubiquitous Release of Exosomal Tumor Suppressor miR-6126 from Ovarian Cancer Cells. |
| Q39298837 | Validation of the Preoperative Platelet-to-Lymphocyte Ratio as a Prognostic Factor in a European Cohort of Patients with Upper Tract Urothelial Carcinoma |
| Q98210962 | lncRNA and Mechanisms of Drug Resistance in Cancers of the Genitourinary System |
| Q52769452 | miR-196b-5p Regulates Colorectal Cancer Cell Migration and Metastases through Interaction with HOXB7 and GALNT5. |
| Q38932823 | microRNAs and Colorectal Cancer |
Search more.